Section 2157. Medication-assisted treatment.
(a) Minimum requirement.--An insurer or MA or CHIP managed care plan shall make available coverage of at least one prescription drug approved by the United States Food and Drug Administration for use in medication-assisted treatment for opioid use disorders, including coverage of at least one of each of the following without prior authorization:
(1) Buprenorphine/naloxone prescription drug combination product.
(2) Injectable and oral naltrexone.
(3) Methadone.
(b) Coverage and cost tier.--If a medication-assisted treatment prescription drug set forth in subsection (a) is covered as a pharmacy benefit, then the insurer or MA or CHIP managed care plan shall cover the prescription drug on the lowest nonpreventive cost tier of the health insurance policy or MA or CHIP managed care plan.
(2157 added Nov. 3, 2022, P.L.2068, No.146)